| View |
|
DRP-6453-07
|
Losartan potassium
|
Unbranded
|
50 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker
|
Mediwin Pharmaceuticals
|
India
|
CLIDP Conversion
|
08 August 2022
|
27 November 2025
|
| View |
|
DRP-8300-09
|
Rosuvastatin (as calcium)
|
Unbranded
|
20 mg
|
Film-Coated Tablet
|
Anti-hypercholesterolemia/Anti-dyslipidemia
|
Stallion Laboratories Pvt. Ltd.
|
India
|
Renewal
|
15 March 2024
|
07 August 2029
|
| View |
|
DRP-9993-01
|
CEFUROXIME (AS AXETIL)
|
CEFUQUEST
|
500 MG
|
FILM-COATED TABLET
|
ANTIBACTERIAL
|
FRIENDS PHARMA (PVT.) LTD.
|
Pakistan
|
CLIDP Conversion
|
08 August 2022
|
13 February 2025
|
| View |
|
DRP-11163-01
|
Piperacillin (as sodium) + Tazobactam (as sodium)
|
Nosamax 2.25
|
2g/250mg
|
Powder for Injection (I.V.)
|
Antibacterial (Penicillin- Beta-Lactamase Inhibitor Combination)
|
Reyoung Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
08 August 2022
|
08 February 2027
|
| View |
|
DRP-11044-01
|
Potassium Citrate
|
K-XR
|
1080 mg
|
Extended-Release Tablet
|
Antiurolithic
|
MAGBRO HEALTHCARE PVT. LTD.
|
India
|
CLIDP Conversion
|
09 August 2022
|
18 January 2027
|
| View |
|
DRP-10998-01
|
Clindamycin (as Phosphate)
|
Clindollen
|
150 mg/mL
|
Solution for Injection (I.M./I.V.)
|
Antibacterial (Lincosamide)
|
Kilitch Drugs (India) Ltd.
|
India
|
CLIDP Conversion
|
09 August 2022
|
31 December 2026
|
| View |
|
HRP-163-13
|
Paracetamol
|
None
|
125 mg/ 5 mL
|
Oral Suspension (Orange Flavor)
|
Analgesic / Antipyretic
|
Azarias Pharmaceutical Laboratories Inc.
|
Philppines
|
CLIDP Conversion
|
09 August 2022
|
12 July 2026
|
| View |
|
DRP-10246-02
|
Ceftriaxone (as sodium)
|
Cephrad
|
1 g
|
Powder for Injection
|
Antibacterial (Third-Generation Cephalosporin)
|
Theon Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
09 August 2022
|
01 October 2026
|
| View |
|
DRP-1213-08
|
PARACETAMOL
|
VALUECETAMOL
|
500MG
|
TABLET
|
ANALGESIC/ANTIPYRETIC
|
J.M. TOLMANN LABORATORIES INC.
|
Philppines
|
CLIDP Conversion
|
09 August 2022
|
24 October 2025
|
| View |
|
DRP-11489-01
|
Piperacillin (as sodium) + Tazobactam (as sodium)
|
Pipetollen
|
2 g/250 mg
|
Powder for Injection (IV Infusion)
|
Antibacterial (Penicillin/Beta-lactamase Inhibitor)
|
Kilitch Drugs (India) Ltd.
|
India
|
CLIDP Conversion
|
09 August 2022
|
17 March 2027
|
| View |
|
DRP-1092-09
|
Co-Amoxiclav
|
Prevaclav 312.5
|
312.5 mg (equivalent to 250 mg Amoxicillin + 62.5 mg Clavulanic acid) per 5 mL
|
Powder for Suspension
|
Antibacterial (Penicillin)
|
Indchemie Health Specialities Private Limited
|
India
|
Renewal
|
17 December 2021
|
14 October 2028
|
| View |
|
DRP-1077-12
|
Co-Amoxiclav
|
Prevaclav 625
|
625 mg
|
Tablet (see reverse for formulation)
|
Antibacterial
|
Indchemie Health Specialities Private Limited
|
India
|
Renewal
|
01 August 2023
|
07 October 2028
|
| View |
|
DRP4368
|
Levofloxacin (as hemihydrate)
|
Televo
|
500 mg
|
Film-Coated Tablet
|
Antibacterial (Quinolone)
|
Zim Laboratories Ltd.
|
India
|
Renewal
|
10 August 2022
|
10 April 2028
|
| View |
|
DRP-5195-06
|
Paracetamol + Tramadol Hydrochloride
|
Promadol
|
325 mg/37.5 mg
|
Film-Coated Tablet
|
Analgesic
|
Stallion Laboratories Pvt. Ltd.
|
India
|
Renewal
|
10 August 2022
|
03 March 2028
|
| View |
|
DR-XY48083
|
Pramipexole dihydrochloride monohydrate
|
Piritan
|
250 mcg
|
Tablet
|
Antiparkinson drug (Dopamine Agonist)
|
Kusum Healthcare Pvt. Ltd.
|
India
|
Initial [Correction]
|
08 April 2024
|
06 June 2027
|
| View |
|
DR-XY48186
|
Enzalutamide
|
Alvogen
|
40 mg
|
Softgel Capsule
|
-
|
Lotus Pharmaceutical Co., Ltd. (Nantou Plant)
|
Taiwan
|
Initial
|
18 July 2022
|
18 July 2027
|
| View |
|
DRP-12356
|
0.9% Sodium Chloride S
|
One-Dex Pnss
|
9mg/mL (0.9% w/v)
|
Solution For I.V. Infusion
|
Electrolyte Solution
|
Abaris Healthcare Pvt. Ltd.
|
India
|
Initial
|
22 July 2022
|
22 July 2027
|
| View |
|
DR-XY48203
|
Sugammadex (As Sodium)
|
None
|
100 mg/mL (200 mg/ 2 mL)
|
Solution For Injection (IV)
|
Antidote
|
USV Private Limited
|
India
|
Initial
|
18 July 2022
|
18 July 2027
|
| View |
|
DR-XY48227
|
Montelukast (as Sodium) + Levocetirizine Hydrochloride
|
Co-Altria
|
10mg/5mg
|
Tablet
|
Leukotriene Receptor Antagonist/ Antihistamine
|
Ajanta Pharma Limited
|
India
|
Initial (Correction
|
22 August 2022
|
26 July 2027
|
| View |
|
DR-XY48222
|
Sugammadex (As Sodium)
|
None
|
100 mg/mL (200 mg/ 2 mL)
|
Solution For Injection (IV)
|
Antidote
|
USV Private Limited
|
India
|
Initial
|
25 July 2022
|
25 July 2027
|